Development of an AAV-based microRNA gene therapy for treating spinocerebellar ataxia type 3

被引：0

作者：

Evers, Melvin

Martier, Raygene

Stricker-Shaver, Janice

Hubener-Schmid, Jeannette

Keskin, Sonay

van Deventer, Sander

Huu Phuc Nguyen

Higgins, Joseph J.

Konstantinova, Pavlina

机构：

来源：

NEUROLOGY | 2019年 / 93卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：E531 / E531

页数：1

共 50 条

[31] Characterization of the rat spinocerebellar ataxia type 3 gene [J].

I. Schmitt ;

T. Brattig ;

M. Gossen ;

O. Riess .

Neurogenetics, 1997, 1 :103-112

[32] Extracellular vesicles for therapy of spinocerebellar ataxia type 3 [J].

Rufino-Ramos, D. ;

Carmona, V. ;

Martins, I. M. ;

Barreira, M. ;

Albuquerque, P. R. ;

Faro, R. ;

Perfeito, R. ;

Nobre, R. J. ;

de Almeida, L. P. .

HUMAN GENE THERAPY, 2019, 30 (11) :A101-A101

[33] AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse [J].

Lee, E. K. ;

Hu, C. ;

Bhargava, R. ;

Ponnusamy, R. ;

Park, H. ;

Novicoff, S. ;

Rozengurt, N. ;

Marescau, B. ;

De Deyn, P. ;

Stout, D. ;

Schlichting, L. ;

Grody, W. W. ;

Cederbaum, S. D. ;

Lipshutz, G. S. .

GENE THERAPY, 2013, 20 (08) :785-796

[34] Development and validation of a recovery and purification process for recombinant AAV-based gene therapy vectors. [J].

Debelak, DJ ;

Well, JR ;

Eith, E ;

Nichols, G ;

Giugler, L ;

Atkinson, EM .

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 :U126-U126

[35] Development of an AAV-Based, RNA-Targeting Gene Therapy for the Treatment of Huntington's Disease [J].

Geddes, Claire E. ;

Roth, Daniela ;

Ta, Angeline ;

Wilson, Alistair ;

Gutierrez, Haydee ;

Narayan, Nandini ;

Angelis, Dimitrios ;

Fang, Lydia ;

Berlin, Aaron ;

Nachtrab, Greg ;

Gibbs, Dan ;

Zisoulis, Dimitrios ;

Batra, Ranjan .

MOLECULAR THERAPY, 2021, 29 (04) :271-271

[36] AAV-based gene therapy prevents neuropathology and results in normal cognitive development in the hyperargininemic mouse [J].

E K Lee ;

C Hu ;

R Bhargava ;

R Ponnusamy ;

H Park ;

S Novicoff ;

N Rozengurt ;

B Marescau ;

P De Deyn ;

D Stout ;

L Schlichting ;

W W Grody ;

S D Cederbaum ;

G S Lipshutz .

Gene Therapy, 2013, 20 :785-796

[37] DEVELOPING AAV-BASED GENE THERAPY FOR ADRENOLEUKODYSTROPHY (X-ALD) [J].

Ma, C. ;

Zhang, Z. ;

Feng, H. ;

Li, C. ;

Chen, L. ;

Chen, J. ;

Lai, L. ;

Lian, Q. .

CYTOTHERAPY, 2019, 21 (05) :E14-E14

[38] Optimization strategies and advances in the research and development of AAV-based gene therapy to deliver large transgenes [J].

Kolesnik, Valeria V. ;

Nurtdinov, Ruslan F. ;

Oloruntimehin, Ezekiel Sola ;

Karabelsky, Alexander V. ;

Malogolovkin, Alexander S. .

CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (03)

[39] Low Endotoxin Control Strategy for an AAV-Based CNS Gene Therapy [J].

Stephansky, Stephen ;

Chen, Li ;

Cai, Ying .

MOLECULAR THERAPY, 2024, 32 (04) :497-497

[40] Assessment of the Novel AAV-Based miQURE™ Gene Therapy in SCA3 Animal Models [J].

Toonen, Lodewijk ;

Nobre, Rui ;

McLoughlin, Hayley ;

Overzier, Maurice ;

Martier, Raygene ;

Huebener-Schmid, Jeannette ;

Brouwers, Cynthia ;

Valles, Astrid ;

van Deventer, Sander ;

Huu Phuc Nguyen ;

van Roon-Mom, Willeke ;

Paulson, Henry ;

de Almeida, Luis Pereira ;

Konstantinova, Pavlina ;

Evers, Melvin M. .

MOLECULAR THERAPY, 2020, 28 (04) :142-143

← 1 2 3 4 5 →